Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on September 12, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Fourier-transform Infrared Spectrometer (FTIR) instrument

Closed
1000266306Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Department of HealthView Agency

NAICS

N/A

Place of Performance

*National Capital Region (NCR), CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Health
View Agency Profile
Office AddressN/A
Contacts
Yvonne MurphyPoint of Contact

Full Description

Show more
Trade Agreement(s): Canadian Free Trade Agreement, Canada–Chile Free Trade Agreement, Canada–Colombia Free Trade Agreement, Honduras Free Trade Agreement, Canada–Korea Free Trade Agreement, Canada, Panama Free Trade Agreement, Canada–Peru Free Trade Agreement. Tendering Procedures: To all pre-qualified suppliers Competitive Procurement Strategy: The responsive bid with the lowest evaluated price will be recommended for award of a contract. Comprehensive Land Claim Agreement: No Nature of the Requirement: RFP # 1000266306 - Fourier-transform Infrared Spectrometer (FTIR) instrument, as issued by: Yvonne Murphy, Senior Procurement Officer Health Canada yvonne.murphy@hc-sc.gc.ca THIS REQUEST IS RESERVED FOR HOLDERS OF SUPPLY ARRANGEMENT # E60PV-19EQUI ONLY, FOR THE PURCHASE OF LABORATORY AND SCIENTIFIC EQUIPMENT, PARTS AND ACCESSORIES, SERVICES AND SUPPLIES. Only Suppliers currently pre-qualified on Supply Arrangement E60PV-19EQUI have been invited to bid. As a requirement of the Supply Arrangement, this notice is published on Government Electronic Tendering Service (GETS) for a period of 40 calendar days. The closing date published on this notice identifies how long the notice will be published. For the closing date of any solicitation under the supply arrangement, invited suppliers should refer to the solicitation documents. Suppliers that do not have a Supply Arrangement for the supply of Laboratory and Scientific Equipment, Parts and Accessories, Services and Supplies with Public Works and Government Services Canada, cannot submit a bid. Any bids received from suppliers not pre-qualified on the Supply Arrangement will not be evaluated. Suppliers may qualify under Supply Arrangement E60PV-19EQUI for Laboratory and Scientific Equipment, Parts and Accessories, Services and Supplies, at any time. Interested suppliers should download solicitation document E60PV-19EQUI/D from CanadaBuys (SAP Ariba) and submit a response as per the requirements of the Request for Supply Arrangement. The Canadian Drug Analysis Centre (CDAC) of Health Canada requires the purchase of a Fourier-transform Infrared Spectrometer (FTIR) with Attenuated Total Reflection (ATR) and Raman spectroscopy modules to ensure that this laboratory has the necessary equipment to continue to fulfill the organization’s mandate, and that the equipment is functioning to a high standard of consistency and reliability. This instrument will be used to identity drugs, drug impurities, cutting agents and other contaminants in synthetic drug samples.